In this issue:
Long-term filgotinib for moderately to severely active UC
Therapeutic escalation in refractory ulcerative proctitis
Using existing mid-end ultrasound machine for point-of-care intestinal ultrasound
Treatment of IBD with steroid-sparing medications is age-dependent
Adverse events in UC patients undergoing colectomy during tofacitinib vs. biologic treatment
Biologics for CD
IBD and hospitalisation risk due to RSV
IBD hospitalisations: televisit vs. traditional outpatient care
1-year effectiveness of upadacitinib vs. tofacitinib for UC
Forecasting IBD incidence and prevalence in Canada
Please login below to download this issue (PDF)